Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Response.

Kaya H, Gümüş S, Uçar E, Aydoğan M, Muşabak U, Tozkoparan E, Bilgiç H.

Chest. 2013 Jan;143(1):274-275. doi: 10.1378/chest.12-2249. No abstract available.

PMID:
23276862
2.

Can omalizumab be effective in chronic eosinophilic pneumonia?

Domingo C, Pomares X.

Chest. 2013 Jan;143(1):274. doi: 10.1378/chest.12-2035. No abstract available.

PMID:
23276861
3.

Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia.

Kaya H, Gümüş S, Uçar E, Aydoğan M, Muşabak U, Tozkoparan E, Bilgiç H.

Chest. 2012 Aug;142(2):513-516. doi: 10.1378/chest.11-1881.

PMID:
22871762
4.

Classification of angioedema without wheals.

Prieto-García A, Marcos C, Caballero T; Spanish Group for Study of Bradykinin-Mediated Angioedema.

Ann Allergy Asthma Immunol. 2016 Feb;116(2):177. doi: 10.1016/j.anai.2015.11.004. No abstract available.

PMID:
26815713
5.

A case of allergic bronchopulmonary aspergillosis treated with omalizumab.

Sastre I, Blanco J, Mata H, García F.

J Investig Allergol Clin Immunol. 2012;22(2):145-7. No abstract available.

6.

Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma.

Tajiri T, Matsumoto H, Hiraumi H, Ikeda H, Morita K, Izuhara K, Ono J, Ohta S, Ito I, Oguma T, Nakaji H, Inoue H, Iwata T, Nagasaki T, Kanemitsu Y, Ito J, Niimi A, Mishima M.

Ann Allergy Asthma Immunol. 2013 May;110(5):387-8. doi: 10.1016/j.anai.2013.01.024. Epub 2013 Feb 23. No abstract available.

PMID:
23622013
7.

Reply: To PMID 23021878.

Calus L, Hellings P, Brusselle G, Bachert C, Gevaert P.

J Allergy Clin Immunol. 2013 Jul;132(1):247-8. doi: 10.1016/j.jaci.2013.04.002. Epub 2013 May 16. No abstract available.

PMID:
23684071
8.

Omalizumab for chronic urticaria.

Altman MC, Naimi DR.

N Engl J Med. 2013 Jun 27;368(26):2528-30. doi: 10.1056/NEJMc1305687#SA3. No abstract available.

PMID:
23802532
9.

Omalizumab for chronic urticaria.

Benelli E, Ventura A.

N Engl J Med. 2013 Jun 27;368(26):2528. doi: 10.1056/NEJMc1305687#SA2. No abstract available.

PMID:
23802531
10.

Omalizumab for chronic urticaria.

Wu K, Long H.

N Engl J Med. 2013 Jun 27;368(26):2527-8. doi: 10.1056/NEJMc1305687#SA1. No abstract available.

PMID:
23802530
11.

Omalizumab for chronic urticaria.

Maurer M, Rosén K, Hsieh HJ.

N Engl J Med. 2013 Jun 27;368(26):2530. doi: 10.1056/NEJMc1305687. No abstract available.

12.

Biologics and the treatment of chronic rhinosinusitis.

Kern RC.

J Allergy Clin Immunol. 2013 Jan;131(1):117-8. doi: 10.1016/j.jaci.2012.11.021. No abstract available.

PMID:
23265697
13.

Should clinicians use omalizumab for the treatment of nasal polyps?

Naclerio RM, Baroody FM, Pinto JM.

J Allergy Clin Immunol. 2013 Jul;132(1):247. doi: 10.1016/j.jaci.2013.04.001. Epub 2013 May 16. No abstract available.

PMID:
23684073
14.

Omalizumab for chronic urticaria.

Casale TB.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):118-9. doi: 10.1016/j.jaip.2013.11.004. No abstract available.

PMID:
24565785
15.

Reply: To PMID 23791510.

MacGlashan D Jr.

J Allergy Clin Immunol. 2014 May;133(5):1494-5. doi: 10.1016/j.jaci.2013.12.1096. Epub 2014 Mar 15. No abstract available.

PMID:
24642142
16.

Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'.

Rosén K, Maurer M, Hsieh H, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T.

Br J Dermatol. 2014 Jul;171(1):15-6. doi: 10.1111/bjd.13075. No abstract available.

PMID:
25066290
17.

Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema.

Azofra J, Díaz C, Antépara I, Jaúregui I, Soriano A, Ferrer M.

Ann Allergy Asthma Immunol. 2015 May;114(5):418-9.e1. doi: 10.1016/j.anai.2015.02.007. Epub 2015 Mar 4. No abstract available.

PMID:
25747788
18.

Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

Sabroe RA.

Br J Dermatol. 2014 Jul;171(1):13-5. doi: 10.1111/bjd.13074. No abstract available.

PMID:
25066289
19.

Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal.

Durack A, Matin RN.

Br J Dermatol. 2014 Jul;171(1):10-3. doi: 10.1111/bjd.13073. No abstract available.

PMID:
25066288
20.

Omalizumab (Xolair) for the treatment of chronic idiopathic urticarial.

Scheinfeld N.

Skinmed. 2014 Sep-Oct;12(5):294-7. Review. No abstract available.

PMID:
25632648

Supplemental Content

Support Center